Search results for:
letermovir
letermovir
Drug Name |
Form |
Strength |
Formulary Unrestricted |
Formulary Restricted |
Non-Formulary |
Interchange |
Prevymis |
SOLUTION, INTRAVENOUS |
240 mg/12 mL, 480 mg/24 mL |
|
|
|
|
Prevymis |
TABLET, ORAL |
240 mg, 480 mg |
|
|
|
|
Last updated: Apr. 25, 2018
Non-formulary. FDA indication for CMV prophylaxis in allogeneic stem cell transplant cases and HH is only involved in autologous stem cell transplants.
Reviewed: 24 April 2018